top headlines
Poolbeg Pharma has received a decision to grant a European [...]
Confo Therapeutics has presented preclinical data supporting the development of [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]
Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]
Grifols has launched Fesilty in the USA, making the fibrinogen [...]
Cellares has secured a $50 million growth equity investment from [...]
Faeth Therapeutics has launched as a publicly traded oncology company [...]
ZoBio has launched a DNA-encoded library (DEL) hit discovery service [...]
